Low KIM-1 levels are associated with improved clinical outcomes in advanced RCC
Published in OncLive, 2025
Coverage on the clinical implications of low circulating KIM-1 levels in advanced renal cell carcinoma.
Marc Machaalani, MD
Postdoctoral Research Fellow
- Boston, MA
- Dana-Farber Cancer Institute
- Google Scholar
- ORCID
- PubMed
- ResearchGate
- X (formerly Twitter)